Stock Market News
Sanofi says arbitration court rejects Boehringer’s Zantac claims
2023.06.20 03:33
© Reuters. A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France June 15, 2022. REUTERS/Benoit Tessier/FILE PHOTO
FRANKFURT (Reuters) – Sanofi (NASDAQ:) said on Tuesday that the International Chamber of Commerce ruled in its favour in an arbitration case over claims by Boehringer Ingelheim that Sanofi should be liable for ongoing Zantac litigation in the United States.
The decision is final and can’t be appealed, the French drugmaker said in its statement.
Boehringer said it had taken note of the arbitral tribunal’s decision and would not comment further.